Results 51 to 60 of about 48,911 (308)
Regular treatment with salmeterol and inhaled steroids for chronic asthma: serious adverse events
, 2009 Epidemiological evidence has suggested a link between beta(2)-agonists and increased asthma mortality. There has been much debate about possible causal links for this association, and whether regular (daily) long-acting beta(2)-agonists are safe ...
Christopher J Cates +5 more
core +1 more source
International Forum of Allergy &Rhinology, EarlyView.ABSTRACT Background Chronic rhinosinusitis (CRS) and allergic rhinitis (AR) are two highly prevalent airway diseases in the United States. While the coexistence of CRS and asthma is well recognized, less is known about the development of new‐onset asthma in CRS, particularly in the context of comorbid AR. This study assessed the impact of CRS and AR on
Austin J. Lee, Mohamad R. Chaaban
wiley +1 more source
The impact of asthma and its treatment on growth: an evidence‐based review
Jornal de Pediatria (Versão em Português), 2019 Objectives: To assess the impact of asthma and its treatment (inhaled corticosteroids and other control medications) on growth. Data sources: The authors searched PubMed (up to August 24, 2018) and screened the reference lists of retrieved articles ...
Linjie Zhang +2 more
doaj +3 more sources
Lung India, 2022 Background: According to the 2019 Global Burden of Disease (GBD) report, India contributes to an estimated 12.9% of global asthma cases (34.3 million) but a disproportionate 42.3% of all global asthma deaths.
Sundeep Salvi +4 more
doaj +1 more source
Inhaled corticosteroids for asthma: impact of practice level device switching on asthma control
, 2009 Background As more inhaled corticosteroid (ICS) devices become available, there may be pressure for health-care providers to switch patients with asthma to cheaper inhaler devices. Our objective was to evaluate impact on asthma control of inhaler device
Williams, Angela E. +17 more
core +1 more source
Extent of Sinus Surgery Is Associated With Disease Control in Biologic Treated Type 2 Dominant CRS
International Forum of Allergy &Rhinology, EarlyView.ABSTRACT Background A greater benefit of biologics is observed after surgery in Type 2 chronic rhinosinusitis with nasal polyps (CRSwNP). However, the extent of surgery remains undefined in many studies. This study evaluated the extent of surgery on disease control in patients receiving biologics for refractory Type 2 dominant CRSwNP.
Nicholas J. Campion +11 more
wiley +1 more source
EFFECT OF MODERATE DOSE OF INHALED BUDESONIDE ON HBA1C IN ASTHMATIC CHILDREN
National Journal of Medical Research, 2019 Objective: The objective of the study was to find out effect of inhaled corticosteroids on HbA1c. Methods: Asthma patients in the age group 5-15 years who were started on moderate doses of inhaled budesonide (400-800 microgram/day) for the first time
Wasim A Wani +4 more
doaj
Three‐dimensional geometric morphometric analysis of diaphragmatic dome motion in COPD patients
The Anatomical Record, EarlyView.Abstract Diaphragmatic dysfunction is a hallmark of chronic obstructive pulmonary disease (COPD), especially in emphysema, where hyperinflation alters diaphragm geometry and impairs inspiratory mechanics. However, quantitative three‐dimensional (3D) assessments of diaphragmatic dome shape and motion across COPD phenotypes are limited.
José M. López‐Rey +5 more
wiley +1 more source
Advances in Respiratory Medicine(1) Background: Sleep-disordered breathing and asthma are often interrelated. Children and adults with asthma are more susceptible to sleep apnea. Inhaled corticosteroids effectively reduce inflammation and prevent structural changes in the airways ...
Marco Zaffanello +5 more
doaj +1 more source
Biomedicines, 2023 Inhaled corticosteroids (ICSs) are widely used in chronic obstructive pulmonary disease (COPD) and in combination with long-acting β2 agonists (LABAs) to reduce exacerbations and improve patient lung function and quality of life.
Rosario Lineros +6 more
doaj +1 more source